ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Senate panel launches probe into Novartis' 'reprehensible' response to Zolgensma data irregularities
August 14, 2019Novartis caught plenty of flack with last week’s revelation that its FDA application for gene therapy Zolgensma contained manipulated data and that the company didn't inform regulators until after its approval. Now it's facing a congressional investigatio
Pharma Sources Insight January 2025
